Back
AstraZeneca PLC Vs. Novo Nordisk AS Industry Stock Comparison
Buy
53
AZN
AstraZeneca PLC
Last Price:
79.43
Seasonality Move:
2.18%
Sell
43
NVO
Novo Nordisk AS
Last Price:
134.71
Seasonality Move:
4.32%
Buy
53
AstraZeneca PLC (AZN)
is a Buy
Is AstraZeneca PLC a Buy, Sell or Hold?
- The current AstraZeneca PLC [AZN] share price is $78.58. The Score for AZN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- AZN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $132.06. The Score for NVO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AZN Stock Price Chart
What is AstraZeneca PLC's stock price today?
-
The AstraZeneca PLC share price today is $78.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AZN is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $132.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
AZN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.15 | Sell |
| Relative Strength Index (14 RSI): | 32.92 | Sell |
| Chaikin Money Flow: | -1163247 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (80.5 - 86.76) | Sell |
| Bollinger Bands (100): | (76.65 - 82.85) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 46.02 | Sell |
| Chaikin Money Flow: | -634415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (132.57 - 137.25) | Sell |
| Bollinger Bands (100): | (129.24 - 140.76) | Sell |
AZN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.5 | Sell |
| 20-day SMA: | 83.39 | Sell |
| 50-day SMA: | 81.6 | Sell |
| 200-day SMA: | 73.15 | Buy |
| 8-day EMA: | 79.83 | Sell |
| 20-day EMA: | 81.66 | Sell |
| 50-day EMA: | 81.38 | Sell |
| 200-day EMA: | 75.43 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 133.94 | Sell |
| 20-day SMA: | 134.74 | Sell |
| 50-day SMA: | 133.59 | Sell |
| 200-day SMA: | 125.7 | Buy |
| 8-day EMA: | 133.94 | Sell |
| 20-day EMA: | 134.12 | Sell |
| 50-day EMA: | 134.25 | Sell |
| 200-day EMA: | 124.76 | Buy |
AstraZeneca PLC Earnings Growth & AZN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.08 per share, an increase this year of $0.41 per share, and an increase next year of $0.61 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.92 per share.
AstraZeneca PLC Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||